Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /002653

Haisco Pharmaceutical Group Co., Ltd.

002653

• SHE: 002653 • Delayed

58.53CNY 5.4%

8.64 USD

As of 7 June 2026, Haisco Pharmaceutical Group Co., Ltd. has a market cap of $9.1B USD, ranking #2389 globally and #386 in China. It ranks #177 in the Healthcare sector, and #6 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

2389

Country Rank

386

Sector Rank

177

Industry Rank

Key Stats

Market Cap

$9.1BUSD

61.6B CNY

Enterprise Value

$9.14BUSD

61.89B CNY

Revenue (TTM)

$747.43MUSD

5.06B CNY

EBITDA (TTM)

$141.01MUSD

955.21M CNY

Net Income (TTM)

$113.39MUSD

767.58M CNY

EBITDA Margin

19%

Profit Margin

15%

PE Ratio

80.6

Forward PE

78.8

PS Ratio

12.2

PB Ratio

12.7

EV/EBITDA

64.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Xiu Lian Fan open_in_new

Employees

5,597

Founded

2000

Website

haisco.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5.4%	3.9%	6.1%	16%	15%	14%	36%	122%	121%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002653 海思科医药集团股份有限公司 Class A ISIN: CNE100001BC7 Shares Out.: Shares Outstanding: 1.12B¹ Shares Float: 519.89M² TV: TradingView: SZSE: 002653 SA: Stock Analysis: SHE: 002653 YF: Yahoo Finance: 002653.SZ GF: Google Finance: SHE: 002653 BA: Barron's: 002653 MS: Morningstar: XSHE: 002653	58.53 CNY	TV: TradingView: SZSE: 002653 SA: Stock Analysis: SHE: 002653 YF: Yahoo Finance: 002653.SZ GF: Google Finance: SHE: 002653 BA: Barron's: 002653 MS: Morningstar: XSHE: 002653

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 74%	16.0	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY -43%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY -54%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY -64%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY -70%	11.5	China
Byhealth Co., Ltd. SHE: 300146	$2.61B 17.67B CNY -71%	24.0	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 314%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 225%	-	United States
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 22%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 21%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR -3.4%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR -7.4%	23.1	India

chevron_leftBack